Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. šŸŒšŸ’ŠšŸ”¬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985ā€“1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. šŸ§ šŸ“ššŸŽ“

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at MƤlardalen University in 1981. šŸ§‘ā€šŸ”¬šŸ’‰šŸ“š

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lillyā€“Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Polandā€™s National Centre for Research and Development. šŸŒšŸ”¬šŸ§ 

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. šŸ§ šŸ’Š

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. šŸ§ šŸ“ššŸ’Š

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at UmeĆ„ University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. šŸŽ“šŸ§ šŸ’”

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. šŸ§ šŸ’ŠšŸŽ“

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. šŸ§ šŸ”¬šŸ’Š His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Assoc . Prof . Dr. Vijay Kumar|Drug Discovery|Editorial Board Member

Published on by Top Pharmaceutical

Assoc . Prof . Dr. Vijay Kumar|Drug Discovery|Editorial Board Member

Assoc . Prof . Dr. Vijay Kumar at Dr B R Ambedkar NIT Jalandhar,India

PROFILEĀ Ā 

scopus

Early Academic Pursuits šŸŽ“

Dr. Vijay Kumarā€™s academic journey is a testament to his dedication to the field of Computer Science and Engineering. He earned his Ph.D. in Computer Engineering from the National Institute of Technology, Kurukshetra, a premier institution renowned for producing leaders in technology and innovation. Prior to his doctorate, he completed his M.Tech. in Computer Science and Engineering from Guru Jambheshwar University of Science & Technology, Hisar, and his B.Tech. in Information Technology from Kurukshetra University, Kurukshetra. This robust foundation in computer science has fueled his career in both academia and research.

Professional Endeavors šŸ‘Øā€šŸ«

Dr. Vijay Kumar serves as the Associate Professor and Head of the Department of Information Technology at Dr. B.R. Ambedkar National Institute of Technology (NIT), Jalandhar. In this role, he has been pivotal in driving academic excellence and fostering a culture of research. He has also taken up significant administrative responsibilities, including serving as the Ph.D. Coordinator and Coordinator for the Department Purchase Committee and Infrastructure and Lab Development initiatives. His leadership has been instrumental in shaping the department’s academic and research ecosystem.

Contributions and Research Focus šŸ§ 

Dr. Kumar’s research contributions span across cutting-edge areas such as:

  • Metaheuristic Techniques: Developing advanced algorithms for solving optimization problems.
  • Deep Learning: Pioneering applications of neural networks in diverse domains.
  • Data Clustering: Enhancing techniques for grouping data for better analysis.
  • Image Mining: Leveraging computational methods to extract meaningful information from images.

His extensive publication record includes high-impact papers in prestigious journals like IEEE Transactions on Vehicular Technology, Multimedia Tools and Applications (Springer), and Elsevierā€™s Vaccine. Some notable works include:

  • A deep-learning framework for detecting deepfakes and enhancing cybersecurity.
  • Novel frameworks for simultaneous clustering and feature selection.
  • A groundbreaking deep network model for visibility restoration in autonomous vehicles.

Dr. Kumar has also co-authored innovative studies on topics like COVID-19 diagnosis using neural networks, lightweight network intrusion detection systems, and vaccine development challenges. His interdisciplinary research bridges computer science with critical real-world applications, from healthcare to environmental sustainability.

Accolades and Recognition šŸ†

Dr. Kumarā€™s contributions to the research community have been widely recognized:

  • Young Teacher Award (2018) by Mody University, Rajasthan for his dedication to teaching and research.
  • Highly Cited Researcher recognition by Web of Science, underscoring the global impact of his research contributions.

These accolades reflect his commitment to advancing knowledge and inspiring the next generation of technologists and researchers.

Impact and Influence šŸŒ

Dr. Kumarā€™s work has far-reaching implications. His research in image mining and data clustering has practical applications in industries such as autonomous driving, cybersecurity, and healthcare. For instance:

  • His development of a Deep Drug Synergy Prediction Network promises to revolutionize pharmaceutical research by predicting drug interactions with greater precision.
  • His contributions to visibility restoration models for autonomous vehicles enhance safety and reliability in transportation.

Through his teaching and mentorship, Dr. Kumar has influenced countless students and young researchers, fostering innovation and encouraging them to push boundaries.

Legacy and Future Contributions šŸš€

Dr. Vijay Kumarā€™s legacy is defined by his relentless pursuit of knowledge and his ability to bridge academia with real-world challenges. As the Head of the Department of Information Technology at NIT Jalandhar, he is poised to shape the future of computer science education and research. His focus on metaheuristics, deep learning, and computational methods will continue to drive advancements in fields ranging from artificial intelligence to bioinformatics.

In the years ahead, Dr. Kumar aims to expand his research into emerging areas such as quantum computing, green IT solutions, and advanced encryption technologies. His commitment to fostering collaboration and innovation ensures that his contributions will resonate for generations to come.

Conclusion āœØ

Dr. Vijay Kumar stands as a beacon of excellence in academia and research. From his foundational academic pursuits to his impactful professional endeavors, he has continually pushed the boundaries of knowledge and innovation. With his robust research portfolio, numerous accolades, and unwavering dedication, Dr. Kumarā€™s influence is set to grow, inspiring a new era of technological breakthroughs and academic achievements.

šŸŽ“PublicationĀ 

Securing big healthcare data using attribute and honey-based encryption in cloud environment

AuthorsĀ  Ā : Kapil, G., Kumar, N., Mourya, A.K., Kumar, V.

  • YearĀ  Ā  Ā  Ā  Ā :2025

Autoencoder-based drug synergy framework for malignant diseases

XcepCovidNet: deep neural networks-based COVID-19 diagnosis

  • AuthorsĀ  Ā : Juneja, A., Kumar, V., Kaur, M., Singh, D., Lee, H.-N.

Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight

  • AuthorsĀ  Ā :Singh, D., DamaÅ”evičius, R., Kumar, V., … Pecetta, S., Rappuoli, R.
  • JournalĀ  Ā  Ā : Vaccine
  • YearĀ  Ā  Ā  Ā  Ā :2024

HMOSHSSA: a novel framework for solving simultaneous clustering and feature selection problems

  • AuthorsĀ  Ā : Kumar, V., Kumari, R., Kumar, S.